Principal Clinical Research Fellow / Honorary Consultant in Neuro-Oncology

The post-holder will be expected to develop Neuro-Oncology research at the UCL Cancer Institute, in conjunction with University College London Hospitals (UCLH) and have an international profile, positioning UCL/UCLH at the forefront in this area. The UCLH/UCL partnership has been awarded Biomedical Research Centre status by the National Institute for Health Research and cancer research is one of its four major themes.

UCL is one of the U.K.'s premier research and teaching Universities (www.ucl.ac.uk), ranked within the top 15 global universities, and has one of the largest Biomedical Faculties in Europe. University College Hospital (UCH) is a new state-of-the-art hospital in central London (http://www.uclh.nhs.uk/), with access to several imaging modalities, including MRI-PET and other functional imaging, and molecular pathological services. In 2012, the new £110 million UCH Macmillan Cancer Centre opened opposite the UCL Cancer Institute, the hub for cancer research and translation research. This is the UK's most advanced out-patient cancer care facility. The UCL Cancer Institute has a total grant income over £100 million, houses over 350 scientists, and includes many clinician scientists among its 57 Group leaders. The Institute is an internationally recognised centre for cancer research, housing state-of-the-art core facilities funded by the CRUK-UCL Centre, including next generation sequencing,
bioinformatics, proteomics, single-cell genomics, FACS, confocal microscopy and quantitative and digital PCR. UCL is an Experimental Cancer Medicine Centre and a Cancer Research UK Major Cancer Centre. UCL are also a key partner in the CRUK City of London Centre, a cancer biotherapeutics hub, funded by a £14m award from CRUK (https://www.colcc.ac.uk/). UCL is a member of the CRUK International Alliance for the Early Detection of Cancer (ACED, https://www.ucl.ac.uk/cancer/research/centres-and-networks/international-alliance-cancer-early-detection)., As London's Global University, we know diversity fosters creativity and innovation, and we want our community to represent the diversity of the world's talent. We are committed to equality of opportunity, to being fair and inclusive, and to being a place where we all belong.We therefore particularly encourage applications from candidates who are likely to be underrepresented in UCL's workforce. These include people from Black, Asian and ethnic minority backgrounds; disabled people; LGBTQI+ people; and for our Grade 9 and 10 roles, women. You can read more about our commitment to Equality, Diversity and Inclusion here : https://www.ucl.ac.uk/equality-diversity-inclusion

The post-holder will be expected to have an established track record in securing high-impact peer reviewed publications and grant funding at an independent level. They will lead a neuro-oncology research group, and will have plans for future grant applications. There are opportunities to develop an educational programme, and to take part in the teaching and mentoring of graduate clinical and non-clinical scientists. This position will form an important part of the wider UCLH/UCL Biomedical Research Centre (BRC) portfolio, and the Cancer Research UK Centre at UCL.

The appointee will be a member of the UCL Cancer Institute, and will seek opportunities to establish collaborations with group leaders in the UCL Queen Square Institute of Neurology. They will contribute to the educational activities of the Institute and its Division of Neurosurgery.

What we offer

As well as the exciting opportunities this role presents we also offer some great benefits some of which are below: 41 Days holiday (including 27 days annual leave 8 bank holiday and 6 closure days) Defined benefit career average revalued earnings pension scheme (CARE) Cycle to work scheme and season ticket loan On-Site nursery On-site gym Enhanced maternity, paternity and adoption pay Employee assistance programme: Staff Support Service Discounted medical insurance